On Friday's news that Biohaven (BHVN -15.34%) withdrew its application for a top investigational drug from an important ...

The biggest move came from Sui ( SUI 9.69%), which has been gaining momentum from users this year, and jumped 68.4% this week ...

Both revenue and profitability declined for Schlumberger on a year-over-year basis during the quarter. The former metric slid ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

It's been a rough year for Nvidia ( NVDA 4.11%). Since 2025 began, Nvidia's stock has fallen by more than 30%, shedding more ...

C3.ai is now trading at just 6.7 times sales, which is significantly lower than its price-to-sales ratio of 11.2 at the end ...

The other big news item for miners this week was Riot Platforms announcing a $100 million credit facility with Coinbase ( ...

Shares of Nvidia ( NVDA 4.41%) are surging higher on Friday. The AI chip giant's stock had gained 4% as of 1:50 p.m. ET and ...

Compounding the robust improvements in sales, AbbVie raised its profitability guidance for the full year. It now expects to post adjusted per-share earnings of $12.09 to $12.29; previously it was ...

For the period, Gilead's revenue clocked in at $6.67 billion, essentially flat over the same quarter of 2024. The company attributed this to sales declines of COVID drug Veklury and oncology products.

Shares of SES AI ( SES 18.54%) soared on Friday, following the battery materials researcher's impressive first-quarter report. The stock rose as much as 45.3% in the morning session, backing down to a ...

Tariffs, trade policy, and the risk of recession have all contributed to market turmoil lately. That's led to a massive increase in volatility in one of the market's biggest stocks. Shares in tech ...